TY - JOUR
T1 - Italian version of the M.D. Anderson Symptom Inventory—Head and Neck Module
T2 - linguistic validation
AU - Greco, A.
AU - Orlandi, E.
AU - Mirabile, A.
AU - Takanen, S.
AU - Fallai, C.
AU - Iacovelli, N. A.
AU - Rimedio, A.
AU - Russi, E.
AU - Sala, M.
AU - Monzani, D.
AU - Rosenthal, D. I.
AU - Gunn, G. B.
AU - Steca, P.
AU - Licitra, L.
AU - Bossi, P.
N1 - Publisher Copyright:
© 2015, Springer-Verlag Berlin Heidelberg.
PY - 2015/3/21
Y1 - 2015/3/21
N2 - Background: Head and neck cancer (HNC) patients can experience symptoms due to the tumor itself or to the treatment, with an impact on health-related quality of life (HRQoL). Patient-reported outcome (PRO) measures pertaining to HRQoL are used in medical research and to support clinical decisions. PRO instrument applicability and cultural adaptation must be tested for each population. The aim of this study is to linguistically validate the Italian translation of the M.D. Anderson Symptom Inventory—Head and Neck Module (MDASI-HN). Methods: Following forward and backward translation of the items of the English MDASI-HN into Italian, it was administered along with a cognitive debriefing to HNC patients able to read and understand Italian language. Individual and group responses are presented using descriptive statistics. Results: From May 2013 through September 2013, 56 patients with HNC (18 during curative treatment, 20 in palliative chemotherapy, and 18 in follow-up period) completed the MDASI-HN followed by accompanying cognitive debriefing. Ninety-nine percent of the individual MDASI-HN items were completed. Average time to complete the MDASI-HN was 8.5 min (range 3–15). Results suggested overall ease of completion, relevance, and comprehensibleness of this translated self-report instrument in this Italian patient population. Conclusions: The Italian version of the MDASI-HN is linguistically valid; future research should explore dimensionality, reliability, and convergent, discriminant, and predictive validity of this patient-reported instrument, in order to use this translated version in outcomes research and clinical settings.
AB - Background: Head and neck cancer (HNC) patients can experience symptoms due to the tumor itself or to the treatment, with an impact on health-related quality of life (HRQoL). Patient-reported outcome (PRO) measures pertaining to HRQoL are used in medical research and to support clinical decisions. PRO instrument applicability and cultural adaptation must be tested for each population. The aim of this study is to linguistically validate the Italian translation of the M.D. Anderson Symptom Inventory—Head and Neck Module (MDASI-HN). Methods: Following forward and backward translation of the items of the English MDASI-HN into Italian, it was administered along with a cognitive debriefing to HNC patients able to read and understand Italian language. Individual and group responses are presented using descriptive statistics. Results: From May 2013 through September 2013, 56 patients with HNC (18 during curative treatment, 20 in palliative chemotherapy, and 18 in follow-up period) completed the MDASI-HN followed by accompanying cognitive debriefing. Ninety-nine percent of the individual MDASI-HN items were completed. Average time to complete the MDASI-HN was 8.5 min (range 3–15). Results suggested overall ease of completion, relevance, and comprehensibleness of this translated self-report instrument in this Italian patient population. Conclusions: The Italian version of the MDASI-HN is linguistically valid; future research should explore dimensionality, reliability, and convergent, discriminant, and predictive validity of this patient-reported instrument, in order to use this translated version in outcomes research and clinical settings.
KW - Head and neck cancer
KW - Italian MDASI-HN
KW - Patient symptoms
KW - Patient-reported outcome
UR - http://www.scopus.com/inward/record.url?scp=84945440592&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84945440592&partnerID=8YFLogxK
U2 - 10.1007/s00520-015-2701-1
DO - 10.1007/s00520-015-2701-1
M3 - Article
C2 - 25791393
AN - SCOPUS:84945440592
SN - 0941-4355
VL - 23
SP - 3465
EP - 3472
JO - Supportive Care in Cancer
JF - Supportive Care in Cancer
IS - 12
ER -